Arthex Biotech
Organization
Grants and prizes
HORIZON-EIC-ACC-BF, First In class oliGo THerapy for Myotonic Dystrophy type 1 (DM1), 190181217, €2.5M, 2023–2025, Dec 21, 2022
Sources: cordis.europa.eu
Organization
HORIZON-EIC-ACC-BF, First In class oliGo THerapy for Myotonic Dystrophy type 1 (DM1), 190181217, €2.5M, 2023–2025, Dec 21, 2022
Sources: cordis.europa.eu